Key result
Creation of a pericardial window for malignant pericardial effusion resulted in no operative deaths, with 26% of patients surviving 1 or more years and 50% dying within 3 months.
Why the study?
Does the creation of a pericardial window provide safe management of malignant pericardial effusion in patients with malignancy?
Population
66 patients with a previously established diagnosis of malignancy and malignant pericardial effusion
Design
Case_series
Follow-up
1 or more years
Authors
Loading...
Supports safety in selected cases; leaves open comparative efficacy versus alternatives given level 5 evidence.
Observational (n=66)
Does the creation of a pericardial window provide safe management of malignant pericardial effusion in patients with malignancy?
Creation of a pericardial window is a safe procedure for managing malignant pericardial effusion, allowing for the continuation of primary malignancy therapy despite poor overall prognosis.
Reitknecht et al. (1985) conducted an observational in Malignant pericardial effusion (n=66). Creation of a pericardial window was evaluated on Survival at 1 or more years. Creation of a pericardial window for malignant pericardial effusion resulted in no operative deaths, with 26% of patients surviving 1 or more years and 50% dying within 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: